Literature DB >> 32898725

Fluorescence-based method for sensitive and rapid estimation of chlorin e6 in stealth liposomes for photodynamic therapy against cancer.

Rupesh Jain1, Rajesh Pradhan1, Siddhanth Hejmady1, Gautam Singhvi1, Sunil Kumar Dubey2.   

Abstract

Chlorin e6 is a chlorine-based porphyrin containing photosensitizer mainly used for the therapy in cancers like neck and head, early-stage lung cancer, and topical skin cancers. The present study provides a comprehensive account of a highly sensitive, precise, and validated method for the quantification of chlorin e6 in its liposomal formulation. This method is based on the systemic study of the fluorescence action of chlorin e6 in acetonitrile solvent. This experiment follows the analytical method validation parameters as per the International Conference on Harmonization (ICH). Chlorin e6 molecule exhibits strong fluorescence at a wavelength of emission 665 nm, upon excitation at a wavelength of excitation 400 nm in acetonitrile. The linearity of the fluorescence concentration plot was observed over a concentration range of 50 to 1000 ng/mL. The developed and validated method was successfully applied for the estimation of encapsulation efficiency in in-house developed stealth liposomes. Also, stock solution stability and photodegradation study of chlorin e6 were further conducted.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chlorin e6; Encapsulation efficiency; Fluorescence spectroscopy; Light degradation study; Photodynamic therapy; Stealth liposomes

Mesh:

Substances:

Year:  2020        PMID: 32898725     DOI: 10.1016/j.saa.2020.118823

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  An insight into photodynamic therapy towards treating major dermatological conditions.

Authors:  Anuradha Dey; Gautam Singhvi; Anu Puri; Prashant Kesharwani; Sunil Kumar Dubey
Journal:  J Drug Deliv Sci Technol       Date:  2022-08-30       Impact factor: 5.062

Review 2.  Emerging innovations in cold plasma therapy against cancer: A paradigm shift.

Authors:  Sunil Kumar Dubey; Neha Dabholkar; Udit Narayan Pal; Gautam Singhvi; Navin Kumar Sharma; Anu Puri; Prashant Kesharwani
Journal:  Drug Discov Today       Date:  2022-05-19       Impact factor: 8.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.